LeonaBio (LONA) Return on Equity (2020 - 2026)

LeonaBio (LONA) has 7 years of Return on Equity data on file, last reported at 0.03% in Q1 2026.

• Quarterly Return on Equity fell 1.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (down 1.0% YoY) and the FY2025 annual result came in at 0.03%, down 3.0% from the prior year.
• Return on Equity grew to 0.03% in Q1 2026 per LONA's latest filing, from 0.04% in the prior quarter.
• Across five years, Return on Equity topped out at 0.0% in Q1 2022 and bottomed at 0.04% in Q4 2025.
• The 5-year median for Return on Equity is 0.01% (2024), against an average of 0.01%.
• The widest annual swing landed in 2022, when Return on Equity changed 0 bps; it then slipped 2 bps in 2025.
• Tracing LONA's Return on Equity over 5 years: stood at 0.0% in 2022, then sank by 111 bps to 0.01% in 2023, then plunged by 124 bps to 0.02% in 2024, then slumped by 90 bps to 0.04% in 2025, then gained by 24 bps to 0.03% in 2026.
• Per Business Quant, the three latest LONA Return on Equity figures stand at 0.03% (Q1 2026), 0.04% (Q4 2025), and 0.01% (Q3 2025).

Peer Comparison